Skip to Content

Senators Urge Biden to Waive Rules That Restrict COVID-19 Vaccine Production

FRIDAY, April 16, 2021 -- The United States should support efforts to temporarily waive intellectual property rules so that nations struggling to vaccinate their populations against COVID-19 can get more vaccines, 10 senators urged in a letter to President Joe Biden.

They wrote that the White House should "prioritize people over pharmaceutical company profits" and that a waiver could open the door for generic or other manufacturers to make more vaccines, the Associated Press reported.

India and South Africa have appealed to the World Health Organization for such a waiver, which is supported by more than 100 nations. "Simply put, we must make vaccines, testing, and treatments accessible everywhere if we are going to crush the virus anywhere," the lawmakers say in the letter, the AP reported.

Drug companies and other opponents claim such a waiver would set a dangerous precedent in allowing scientists worldwide to copy American and European companies' research.

The Biden administration has said it is studying the matter and did not respond to the AP's request for comment on the senators' letter.

Associated Press Article

© 2021 HealthDay. All rights reserved.

Read this next

New Heart Failure Diagnosed in Hospitalized COVID-19 Patients

FRIDAY, May 14, 2021 -- Patients hospitalized with COVID-19 may be at risk for developing new heart failure, according to a research letter published in the May 4 issue of the...

Many Adults Unprotected Against Vaccine-Preventable Disease

FRIDAY, May 14, 2021 -- Many U.S. adults remain unprotected against vaccine-preventable diseases, according to research published in the May 14 issue of the U.S. Centers for...

CDC: COVID-19 Vaccine Can Be Given Along With Other Shots

THURSDAY, May 13, 2021 -- The U.S. Centers for Disease Control and Prevention said Wednesday that COVID-19 vaccines can be given along with other childhood shots, CNN reported...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.